Experience with clinical use of Sandimmun Neoral in renal transplant patients
Min, Z.L.; Zhao, M.; Zhu, Y.H.; Qi, J.; Wang, L.M.; Wang, Y.W.
Transplantation Proceedings 28(3): 1356-1357
1996
ISSN/ISBN: 0041-1345 PMID: 8658692 Document Number: 458639
Document emailed within 1 workday
Related Documents
Neumayer, H.H.; Färber, L.; Haller, P.; Kohnen, R.; Maibücher, A.; Schuster, A.; Vollmar, J.; Waiser, J. 1994: Conversion from Sandimmun to Sandimmun Neoral in patients with stable renal allografts: results after 1 month Transplantation Proceedings 26(5): 2944-2948Taesch, S.; Niese, D.; Mueller, E.A. 1994: Sandimmun neoral, a new oral formulation of cyclosporin a with improved pharmacokinetic characteristics: safety and tolerability in renal transplant patients Transplantation Proceedings 26(6): 3147-3149
Tsang, W.K.; Ho, Y.W.; Tong, K.L.; Chan, W.H.; Chan, A. 1996: Safety, tolerability, and pharmacokinetics of Sandimmun Neoral: conversion study in stable renal transplant recipients Transplantation Proceedings 28(3): 1330-1332
Massari, P.U.; Grosso, S.; de Boccardo, G.; Vásquez, M.C.; Schiavelli, R.O.; Sabbatiello, R.R.; Casadei, D.H.; Rial, M.C.; Jost, L.J.; Túrin, M.D.; Agost Carreño C, A.; Maggiora, E.C.; Gadea, M.M. 1996: A randomized, controlled, double-blind study of the safety and tolerability of Sandimmun Neoral in stable renal transplant patients. Argentine Multicentre Study Group Transplantation Proceedings 28(6): 3365-3367
Färber, L.; Maibücher, A.; Geissler, F.; Gutzler, F.; Wiesinger, F.O.; Winkler, M. 1994: Favourable clinical results of Sandimmun-Neoral in malabsorbing liver and heart transplant recipients Transplantation Proceedings 26(5): 2988-2993
Babarykin, D.; Amerika, D.; Adamsone, I.; Valinietse, M.; Rosental, R. 1996: Transfer of patients with kidney grafts to Sandimmun Neoral normalizes the calcium level in erythrocyts Transplantation Proceedings 28(6): 3137
Holt, D.W.; Mueller, E.A.; Kovarik, J.M.; van Bree, J.B.; Richard, F.; Kutz, K. 1995: Sandimmun neoral pharmacokinetics: impact of the new oral formulation Transplantation Proceedings 27(1): 1434-1437
Kovarik, J.; Zlabinger, G.J.; Wolfram, J.; Pecherstorfer, M.; Watschinger, B.; Traindl, O.; Pohanka, E.; Sonnleitner, A.; Ulrich, W. 1989: OKT3 monoclonal antibody treatment in renal transplant recipients--clinical experience in 49 patients Transplantation Proceedings 21(1 Part 2): 1748-1752
Odone, P.; Iberti, M. 1999: Switching to Neoral in patients with a stable kidney transplant. Retrospective study Minerva Urologica e Nefrologica 51(2): 79-83
Bordes-Aznar, J.; Mancilla, E.; Rosenblum, M.; Gabilondo, F.; Orozco, R.; Angeles, A.; Alberú, J. 1992: Malignant neoplasms in renal transplant patients: a 24-year experience Transplantation Proceedings 24(5): 1802-1803
Maes, B.D.; Claes, K.; Coosemans, W.; Evenpoel, P.; Kuypers, D.; Pirenne, J.; Vanrenterghem, Y. 2002: Cessation of steroids in stable renal transplant patients: the Leuven experience Clinical Transplants 2002: 181-189
Ianhez, L.E.; Chocair, P.R.; Fonseca, J.A.; Azevedo, L.S.; de Paula, F.J.; David Neto, E.; Romão Júnior, J.E.; Galvão, M.M.; de Castro, M.C.; Arap, S. 1991: Cyclosporin A: experience of the Renal Transplant Unit of the Clinical Hospital of the Medical College of the University of Sao Paulo AMB: revista da Associacao Medica Brasileira 37(2): 67-72
Liu, W.J.; Zaki, M. 2004: Medication compliance among renal transplant patients: a Hospital Kuala Lumpur experience Medical Journal of Malaysia 59(5): 649-658
Grant, D.; Rochon, J.; Levy, G. 1996: Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group Transplantation Proceedings 28(4): 2232-2233
Mirza, S.; Mahmud, S.N.; Abideen, Z.U.; Aziz, T.; Akhter, S.; Baloch, B.K. 2019: Overcoming the Immunological Barrier in Highly HLA Sensitized Renal Transplant Recipients - a Desensitization Experience from a Transplant Center in Pakistan JPMA. Journal of the Pakistan Medical Association 69(4): 584-587
Stegall, M.D. 2010: Clinical management of renal transplant patients with donor-specific alloantibody: the state of the art Clinical Transplants 2010: 307-315
Pethig, K.; Geiger, M.; Korn, A.; Grote, M.; Christians, U.; Wahlers, T. 1996: Follow-up after conversion to Neoral in stable heart transplant recipients Transplantation Proceedings 28(4): 2282-2284
Atkison, P.R.; Grant, D.R.; Williams, S.E.; Howard, J.; Wall, W.J.; Stiller, C.R. 1994: Sandimmune Neoral in paediatric liver transplant recipients with malabsorption of cyclosporin a Transplantation Proceedings 26(5): 2953-2954
Wie, S.H.; Song, H.C.; Kim, Y.R.; Yoon, S.A.; Lee, S.H.; Yang, C.W.; Kim, Y.S.; Kim, S.Y.; Kang, M.W.; Bang, B.K. 1996: Immunocytochemical assay for cytomegalovirus detection in peripheral blood for renal transplant patients in clinical practice Transplantation Proceedings 28(3): 1505-1506
Levy, G.A. 1996: Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral Transplantation Proceedings 28(4): 2252-2253